Interim safety data on the FRAGMATIC trial: a randomised phase III clinical trial investigating the effect of FRAGMin (R) added to standard therapy in patients with lung cancer

Detalles Bibliográficos
Autores principales:	Macbeth, F, Griffiths, G, Noble, S, Burns, S, Maughan, T
Formato:	Journal article
Publicado:	2009

Ejemplares similares